drug access

Views & Analysis

The impact of the debate on the Right-to-Try laws in the US and what needs to be done to improve access to innovative drugs.

Views & Analysis

Impact of putting access to medicine at the core of pharma businesses.

News

Merck's drug for tumours associated with rare disease neurofibromatosis type 1, Ezmekly, has been cleared for NHS use in children as young as two.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.